Positive News SentimentPositive NewsNASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis $1.60 -0.09 (-5.33%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.59 -0.01 (-0.63%) As of 06/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DocGo Stock (NASDAQ:DCGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DocGo alerts:Sign Up Key Stats Today's Range$1.55▼$1.7050-Day Range$1.28▼$2.4052-Week Range$1.23▼$5.68Volume1.85 million shsAverage Volume769,270 shsMarket Capitalization$163.17 millionP/E RatioN/ADividend YieldN/APrice Target$3.56Consensus RatingModerate Buy Company OverviewDocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More… DocGo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreDCGO MarketRank™: DocGo scored higher than 48% of companies evaluated by MarketBeat, and ranked 700th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDocGo has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has only been the subject of 3 research reports in the past 90 days.Read more about DocGo's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-68.00% Earnings GrowthEarnings for DocGo are expected to decrease by -68.00% in the coming year, from $0.25 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is -80.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is -80.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDocGo has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.01% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in DocGo has recently increased by 21.37%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.01% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in DocGo has recently increased by 21.37%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentDocGo has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for DocGo this week, compared to 3 articles on an average week.Search Interest4 people have searched for DCGO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $58,200.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address DCGO Stock News HeadlinesDocGo Inc. Rings the Closing BellJune 20, 2025 | nasdaq.comDocGo Announces Upcoming Participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025June 18, 2025 | businesswire.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. | Timothy Sykes (Ad)DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare ConferenceJune 2, 2025 | businesswire.comKuehn Law Encourages Investors of DocGo, Inc. to Contact Law FirmMay 30, 2025 | globenewswire.comKuehn Law Encourages Investors of DocGo, Inc. to Contact Law FirmMay 29, 2025 | prnewswire.comDocGo Wins "Compliance Management Innovation Award" in 2025 MedTech Breakthrough Awards ProgramMay 19, 2025 | finance.yahoo.comDocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards ProgramMay 19, 2025 | businesswire.comSee More Headlines DCGO Stock Analysis - Frequently Asked Questions How have DCGO shares performed this year? DocGo's stock was trading at $4.24 on January 1st, 2025. Since then, DCGO stock has decreased by 62.3% and is now trading at $1.60. View the best growth stocks for 2025 here. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) issued its quarterly earnings data on Thursday, May, 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.08. The business had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. DocGo had a negative net margin of 0.12% and a positive trailing twelve-month return on equity of 2.52%. Read the conference call transcript. Who are DocGo's major shareholders? Top institutional shareholders of DocGo include WCM Investment Management LLC (3.18%), Punch & Associates Investment Management Inc. (2.16%), Jefferies Financial Group Inc. (1.99%) and P.A.W. Capital Corp (1.96%). Insiders that own company stock include Lee Bienstock, Adriaan Stephanus Oberholzer, James M Travers, Anthony Capone, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DocGo own? Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings5/08/2025Today6/28/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:DCGO CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees4,407Year FoundedN/APrice Target and Rating Average Stock Price Target$3.56 High Stock Price Target$5.50 Low Stock Price Target$1.45 Potential Upside/Downside+122.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E Ratio26.67 Forward P/E Ratio6.40 P/E GrowthN/ANet Income$19.99 million Net Margins-0.12% Pretax Margin-0.53% Return on Equity2.52% Return on Assets1.70% Debt Debt-to-Equity RatioN/A Current Ratio2.44 Quick Ratio2.44 Sales & Book Value Annual Sales$616.55 million Price / Sales0.26 Cash Flow$0.42 per share Price / Cash Flow3.78 Book Value$3.09 per share Price / Book0.52Miscellaneous Outstanding Shares101,980,000Free Float99,229,000Market Cap$163.17 million OptionableOptionable Beta0.94 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:DCGO) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.